Aspen Technology Valuation
Is AZPN1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AZPN1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AZPN1 * (MX$3563.45) is trading above our estimate of fair value (MX$1975.28)
Significantly Below Fair Value: AZPN1 * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AZPN1 *?
Other financial metrics that can be useful for relative valuation.
What is AZPN1 *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$12.61b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 12x |
Enterprise Value/EBITDA | 40.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does AZPN1 *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 10.2x | ||
MANH Manhattan Associates | 13.4x | 10.1% | US$12.9b |
XRO Xero | 13.1x | 13.4% | AU$18.3b |
DOCU DocuSign | 4.2x | 6.0% | US$11.7b |
DT Dynatrace | 10.2x | 14.8% | US$13.9b |
AZPN1 * Aspen Technology | 11.9x | 9.6% | Mex$12.6b |
Price-To-Sales vs Peers: AZPN1 * is expensive based on its Price-To-Sales Ratio (11.9x) compared to the peer average (10.2x).
Price to Earnings Ratio vs Industry
How does AZPN1 *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: AZPN1 * is expensive based on its Price-To-Sales Ratio (11.9x) compared to the Global Software industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is AZPN1 *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 11.9x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AZPN1 *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$3,345.59 0% | 30.6% | Mex$4,372.38 | Mex$617.28 | n/a | 9 |
Apr ’25 | Mex$3,563.45 | Mex$3,309.02 -7.1% | 30.5% | Mex$4,351.86 | Mex$614.38 | n/a | 9 |
Mar ’25 | n/a | Mex$3,309.02 0% | 30.5% | Mex$4,351.86 | Mex$614.38 | n/a | 9 |
Feb ’25 | n/a | Mex$3,338.15 0% | 30.5% | Mex$4,395.21 | Mex$620.50 | n/a | 9 |
Jan ’25 | n/a | Mex$3,250.35 0% | 32.9% | Mex$4,388.30 | Mex$619.52 | n/a | 8 |
Dec ’24 | n/a | Mex$3,187.89 0% | 32.7% | Mex$4,385.24 | Mex$619.09 | n/a | 8 |
Nov ’24 | n/a | Mex$3,243.65 0% | 32.9% | Mex$4,588.80 | Mex$647.83 | n/a | 8 |
Oct ’24 | n/a | Mex$2,979.48 0% | 33.0% | Mex$4,341.53 | Mex$612.92 | n/a | 8 |
Sep ’24 | n/a | Mex$2,979.48 0% | 33.0% | Mex$4,341.53 | Mex$612.92 | n/a | 8 |
Aug ’24 | Mex$2,905.02 | Mex$2,909.69 +0.2% | 33.3% | Mex$4,316.92 | Mex$609.45 | n/a | 8 |
Jul ’24 | n/a | Mex$3,378.07 0% | 33.4% | Mex$4,533.72 | Mex$640.05 | n/a | 8 |
Jun ’24 | n/a | Mex$3,378.07 0% | 33.4% | Mex$4,533.72 | Mex$640.05 | n/a | 8 |
May ’24 | Mex$4,219.62 | Mex$3,485.06 -17.4% | 33.0% | Mex$4,601.63 | Mex$649.64 | n/a | 8 |
Apr ’24 | n/a | Mex$3,787.23 0% | 33.5% | Mex$5,262.66 | Mex$676.63 | Mex$3,563.45 | 8 |
Mar ’24 | n/a | Mex$3,787.23 0% | 33.5% | Mex$5,262.66 | Mex$676.63 | n/a | 8 |
Feb ’24 | Mex$3,583.66 | Mex$3,787.23 +5.7% | 33.5% | Mex$5,262.66 | Mex$676.63 | n/a | 8 |
Jan ’24 | n/a | Mex$4,480.62 0% | 35.8% | Mex$5,614.24 | Mex$714.18 | n/a | 7 |
Dec ’23 | Mex$4,560.27 | Mex$4,480.62 -1.7% | 35.8% | Mex$5,614.24 | Mex$714.18 | n/a | 7 |
Nov ’23 | n/a | Mex$4,480.62 0% | 35.8% | Mex$5,614.24 | Mex$714.18 | n/a | 7 |
Oct ’23 | n/a | Mex$3,875.69 0% | 35.9% | Mex$5,147.40 | Mex$726.69 | n/a | 7 |
Sep ’23 | n/a | Mex$3,764.83 0% | 35.3% | Mex$5,075.70 | Mex$716.57 | n/a | 7 |
Aug ’23 | n/a | Mex$3,388.12 0% | 37.1% | Mex$4,715.69 | Mex$738.11 | Mex$2,905.02 | 8 |
Jul ’23 | n/a | Mex$3,277.27 0% | 36.6% | Mex$4,656.51 | Mex$728.85 | n/a | 8 |
Jun ’23 | Mex$3,810.59 | Mex$3,011.58 -21.0% | 30.5% | Mex$3,846.28 | Mex$721.18 | n/a | 9 |
May ’23 | n/a | Mex$3,107.37 0% | 30.4% | Mex$3,936.61 | Mex$738.12 | Mex$4,219.62 | 9 |
Apr ’23 | n/a | Mex$3,107.37 0% | 30.4% | Mex$3,936.61 | Mex$738.12 | n/a | 9 |
Analyst Forecast: Target price is lower than the current share price.